- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02273687
Time-motion-mode Ultrasound Diaphragm Measures in Patients With Acute Respiratory Distress in Emergency Department (EDDRAPro)
Analysis of Time-motion-mode Ultrasound Diaphragm Measures in Patients With Acute Respiratory Distress in Emergency Department: Predicting Respiratory Prognosis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The secondary objectives of this study are:
A-determine a prognostic threshold for diaphragmatic excursion measures able to predict the use of mechanical ventilation (invasive or not) in the first four hours.
B-to study the association between CDA values and persistence of respiratory distress during the first 4 hours of care among patients who, at 4 hours, are not mechanically ventilated.
C-to study the association between CDA values and respiratory re-exacerbation or a continuing need for mechanical ventilation during the 24 first hours after admission to the emergency room D-to study the association between diaphragmatic excursion measures made after initial emergency care (at 4 hours; =CDH4), and the persistence of respiratory distress at 4 hours, in patients who at 4 hours are not mechanically ventilated.
E-to study the association between CDH4 values and respiratory re-exacerbation during the 24 first hours after admission to the emergency room among patients who, at 4 hours, are not mechanically ventilated F-to study the association between changes in values of diaphragmatic excursion measure before and after initial emergency care (CDA → CDH4) and respiratory re-exacerbation during the 24 first hours after admission to the emergency room among patients who, at 4 hours, are not mechanically ventilated.
G-analyze patient outcomes by subgroup according to diagnosis (decompensated COPD, OAP, lung disease, asthma, pleural disease).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Nîmes, France, 30029
- CHRU de Nîmes - Hôpital Universitaire Carémeau
-
Perpignan, France, 66046
- CH de Perpignan - Hôpital Saint Jean
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- The patient has given informed consent (and signed the consent form) or, in case of an emergency situation, an investigator has committed to obtaining the consent of the patient as soon as his/her condition permits
- Patient affiliated with or beneficiary of a health insurance plan
- Acute Respiratory Distress (DRA) defined by: (1) respiratory rate > 25 and/or signs of struggle and hypoxia AND (2) SpO2 values < 90% and/or [pH < 7.35 and pCO2 > 6 kPa (45 mm Hg)]
- Breathing spontaneously (no ventilation)
Exclusion Criteria:
- Patient currently participating in or having participated in another interventional study in the previous three months, or patient in an exclusion period determined by a previous study
- Patient under judicial protection or any kind of guardianship
- Refusal to sign the consent
- Patient pregnant, parturient, or lactating
- Neurological or neuromuscular disease modifying the operation of the diaphragm without any decompensation (Polyneuropathy, Lou Gehrig's disease, Myasthenia ...)
- Patient who received mechanical ventilation at home
- Patient who received treatment by mechanical ventilation during the pre-hospitalization care phase
- Patient admitted with respiratory failure requiring immediate installation of a mechanical ventilation and thus not allowing the performance of two ultrasound measurements
- Patient suffering from a pneumothorax
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Prognostic study population
The study population consists of patients treated for acute respiratory distress in the emergency department at the Nîmes University Hospital. See inclusion and exclusion criteria. Intervention: Diaphragmatic ultrasound |
Diaphragmatic ultrasound will be performed by the physician supporting the patient on arrival and also at 4 hours later in the beginning of therapeutic management. The patient will be monitored for 24 hours following inclusion. The exams will all be done with the same ultrasound system (Vivid S6 GE Ultrasound) and a phased array probe, also called a cardiac probe. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of diaphragmatic excursion by M-mode ultrasound
Time Frame: Day 0, baseline
|
in centimeters
|
Day 0, baseline
|
|
Use of ventilation within the first 4 hours
Time Frame: Day 0, baseline + 4 hours
|
yes/no
|
Day 0, baseline + 4 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of diaphragmatic excursion by M-mode ultrasound
Time Frame: Day 0, baseline + 4 hours
|
in centimeters
|
Day 0, baseline + 4 hours
|
|
Acute respiratory distress signs within the first 4 hours
Time Frame: Day 0, baseline + 4 hours
|
yes/no
|
Day 0, baseline + 4 hours
|
|
Signs of respiratory re aggravation at 24 hours
Time Frame: Day 1
|
yes/no
|
Day 1
|
|
Diagnosis
Time Frame: Day 1
|
qualitative variable: decompensated COPD, OAP, pneumonia, asthma, or pleural pathology
|
Day 1
|
Collaborators and Investigators
Investigators
- Principal Investigator: Xavier Bobbia, MD, Centre Hospitalier Universitaire De Nimes
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LOCAL/20143/XBAC-01
- 2014-A00511-46 (Other Identifier: ANSM)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.